Hui Qiu

Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors

Wuhan

China

  • Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors

SCHOLARLY PAPERS

2

DOWNLOADS

52

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

A Prognostic Risk Score Based on Integration of 9-Gene Expression and 5-Microbial Abundance Improves the Power to Predict Overall Survival of Patients with Cervical Squamous Carcinoma

Number of pages: 20 Posted: 26 Jul 2021
Hui Yang, Sufang Tian, Chunxu Yang, Min Chen, Shaoxing Sun, Zijie Mei, Conghua Xie, Yunfeng Zhou, Jian-Hua Mao and Hui Qiu
Wuhan University - Hubei Cancer Clinical Study Center, Wuhan University - Department of Pathology, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan University - Department of Radiation and Medical Oncology, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors, University of California, Berkeley - Biological Systems and Engineering Division and Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors
Downloads 41 (848,305)

Abstract:

Loading...

cervical squamous cancer; prognosis; gene prognostic signature; microbiome prognostic signature; survival analysis

2.

Improved Outcomes of Palliative Radiotherapy Combined with Immune Checkpoint Inhibitors in Recurrent or Metastatic Cervical Cancers

Number of pages: 53 Posted: 28 Jun 2024
Xinyu Pan, Xiaowan Guo, Juan Wang, Chunxu Yang, Min Chen, Hui Qiu and Qiuji Wu
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Wuhan University - Hubei Key Laboratory of Tumor Biological Behaviors and affiliation not provided to SSRN
Downloads 11 (1,165,506)

Abstract:

Loading...

Palliative radiotherapy, immune checkpoint inhibitors, recurrent or metastatic cervical cancers, clinical outcomes